LARIAT RS SUTURE DELIVERY SYSTEM
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $1.3M | 219 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 219 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TO PULMONARY VEIN ISOLATION FOR PERSISTENT OR LONGSTANDING PERSISTANT ATRIAL FIBRILLATION (AMAZE STUDY) | ATRICURE, INC. | $901,231 | 0 |
| LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TO PULMONARY VEIN ISOLATION FOR PERSISTENT OR LONGSTANDING PERSISTANT ATRIAL FIBRILLATION (AMAZE STUDY) | AtriCure, Inc. | $407,375 | 0 |
Top Doctors Receiving Payments for LARIAT RS SUTURE DELIVERY SYSTEM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Lake Success, NY | $1.3M | 219 |
Manufacturing Companies
- ATRICURE, INC. $901,231
- AtriCure, Inc. $407,375
Product Information
- Type Device
- Total Payments $1.3M
- Total Doctors 0
- Transactions 219
About LARIAT RS SUTURE DELIVERY SYSTEM
LARIAT RS SUTURE DELIVERY SYSTEM is a device associated with $1.3M in payments to 0 healthcare providers, recorded across 219 transactions in the CMS Open Payments database. The primary manufacturer is ATRICURE, INC..
Payment data is available from 2020 to 2020. In 2020, $1.3M was paid across 219 transactions to 0 doctors.
The most common payment nature for LARIAT RS SUTURE DELIVERY SYSTEM is "Unspecified" ($1.3M, 100.0% of total).
LARIAT RS SUTURE DELIVERY SYSTEM is associated with 2 research studies, including "LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TO PULMONARY VEIN ISOLATION FOR PERSISTENT OR LONGSTANDING PERSISTANT ATRIAL FIBRILLATION (AMAZE STUDY)" ($901,231).